Pluri, a biotech company specialising in cell-based solutions, has announced a $6.5 million investment The investment will involve the issuance of approximately 1.38 million shares of Pluri’s common stock Weinstein, who will join Pluri's board of directors as part of the agreement, brings over 20 years of Pluri's CEO, Yaky Yanay, said: “At Pluri, we are committed to pioneering sustainable and impactful solutions #Pluri #cellbasedcocoa #cellbasedchocolate #Kokomodo #investment #acquisition

Pluri has entered a strategic collaboration with Wilk Technologies to develop unique medical food intended The partnership will combine Pluri’s 3D cell expansion tech with Wilk’s expertise in developing cultured This collaboration presents an opportunity to leverage Pluri’s 3D cell expansion technology with Wilk Pluri’s CEO and president, Yaky Yanay, added: “At Pluri, our mission is to leverage cell-based technology #Pluri #Wilk

Israeli biotech firm Pluri has announced the successful completion of a $3.5 million private placement Under the terms of the latest agreement, Pluri will issue 759,219 shares at a price of $4.61 per share This influx of capital is designed to support Pluri's strategic initiatives as it seeks to expand its About Pluri Pluri is a biotechnology firm specialising in cell-based solutions aimed at addressing critical #Pluri #biotech #investment #Israel #agtech #foodtech #cultivatedfood

Israeli biotech company Pluri has announced that it has received a new patent approval for its 3D bioreactor titled 'A System for 3D Cultivation of Plant Cells and Methods of Use,' represents a breakthrough in Pluri's Yaky Yanay, Pluri's CEO and president, said: “PluriAgtech’s patented technology can be used for a wide Pluri’s cell-based coffee Pluri’s president and CEO, Yaky Yanay, said: “We believe deeply in the power #Pluri #cellbasedcoffee

Biotech firm Pluri has announced a strategic proof of concept (POC) agreement with what it refers to The collaboration is set to leverage the strengths of both companies – Pluri's expertise in cell-expansion Yaky Yanay, CEO and president of Pluri, said: “As the global population expands, resource competition It has been a busy year so far for Pluri – in March, Pluri received new patent approval for its 3D bioreactor #Pluri #Israel #plantcellcultivation

Biotech company Pluri has announced strategic investments in its subsidiary, Ever After Foods. Ever After Foods is Pluri’s majority-owned joint venture with Israeli food giant Tnuva Food-Tech Incubator , and has exclusive licensing rights to use Pluri’s technology and intellectual property to develop, Leveraging Pluri's technology, Ever After Foods has swiftly advanced its scalable production platform #EverAfterFoods #Pluri #Israel

.” ✨ Pluri ✨ Israeli biotech firm Pluri identified a critical gap in scalable adherent cell production Pluri’s proprietary bioreactor system provides a 3D micro-environment for cells that can mimic various created a design of packet bed flow chambers connected to a feeding bioreactor,” a spokesperson for Pluri , has emerged as a trailblazer in the cultivated meat industry, leveraging Pluri’s bioreactor technologies Founded as a strategic partnership between Pluri and Israel’s largest food producer Tnuva Group, Ever

Ever After Foods is Pluri's majority-owned joint venture with Israeli food giant Tnuva Food-Tech Incubator , and has exclusive licensing rights to use Pluri's technology and intellectual property to develop,

Ever After Foods, formerly known as Plurinuva, has launched its patented bioreactor platform to produce Yaky Yanay, Pluri CEO and president and chairman of Ever After Foods, said: “In less than a year, Ever

Pluri Israeli biotech firm Pluri is advancing sustainable food production through its proprietary 3D including a safer and more efficient platform for producing a range of plant metabolites,” Nimrod Barzvi, Pluri “PluriAgtech offers cell-based solutions to optimise crop yields, create more resilient plants and deliver Pluri’s proprietary 3D cell cultivation platform mimics the natural function of plant cells by creating The cells start secreting bioactives that can be scaled up in Pluri’s modular Matrix bioreactor.

In Australia, I worked at Magic Valley, a company pioneering the use of induced pluripotent stem cell

achieving significant milestones such as the development of animal component-free lamb using induced pluripotent